News & Media

• 2024.06.07 News
• Business Briefing Held at Osaka University TAT Cyclotron Building

• 2024.05.30 News
• Initiation of Clinical Trial Using Astatine for Refractory Prostate Cancer

• 2023.08.25 News
• Alpha Fusion Begins R&D for Novel Astatine Labeling Platform Technology

• 2023.07.21 News
• Alpha Fusion and QST Commence R&D for Multiple Novel Astatine Therapeutics Targeting Proteins Highly Expressed in Tumors

• 2023.06.12 News
• Alpha Fusion closes Series A with New Equity Participation by Toshiba Energy Systems